APR 12, 2021 11:16 AM PDT

Using antibodies to treat melanoma

New research presented at the American Association of Cancer Research (AACR) virtual annual meeting this week from the Yale Cancer Center highlights an antibody that could be used to treat melanoma. The antibody is able to target tumors and enter cells in order to stimulate an immune response. 

"Most approaches rely on direct injection into tumors of ribonucleic acids (RNAs) or other molecules to boost the immune response, but this is not practical in the clinic, especially for patients with advanced cancer," said senior author of the study Peter M. Glazer, MD, PhD. Glazer is Chair of the Department of Therapeutic Radiology at Yale as well as Chief of Radiation Oncology at Smilow Cancer Hospital. "In this study, we can deliver immunostimulatory RNA to tumors in vivo following systemic administration."

Lead author of the study,  Elias Quijano, and along with co-author, Yanfeng Liu, explain that they conducted their study on mice with melanoma tumors and demonstrated almost complete tumor suppression upon intravenous injection of antibody/RNA complexes.

"These results are very encouraging," added Glazer. "They highlight a novel approach for the systemic delivery of immunostimulatory RNAs in a targeted manner that may one day offer therapeutic advantages for difficult to treat cancers like melanoma, over current approaches."

Sources: Yale University, Science Daily

About the Author
BA Environmental Studies
Kathryn is a curious world-traveller interested in the intersection between nature, culture, history, and people. She has worked for environmental education non-profits and is a Spanish/English interpreter.
You May Also Like
JUL 21, 2022
Cell & Molecular Biology
'Junk' DNA May Stall Replication, Increasing Cancer Risk
JUL 21, 2022
'Junk' DNA May Stall Replication, Increasing Cancer Risk
Huge sections of the human genome are made up of highly repetitive sequences, areas where bases like ATATAT repeat in lo ...
SEP 25, 2022
Genetics & Genomics
The next generation of library preparation solutions for DNA sequencing
SEP 25, 2022
The next generation of library preparation solutions for DNA sequencing
The next generation of library preparation solutions for DNA sequencing  Since the completion of the Human Genome P ...
OCT 04, 2022
Cancer
The NCI Welcomes First Woman Director: Monica M. Bertagnolli, MD
OCT 04, 2022
The NCI Welcomes First Woman Director: Monica M. Bertagnolli, MD
In August, President Biden announced his intention to appoint Dr. Monica M. Bertagnolli as the newest director of the Na ...
OCT 18, 2022
Immunology
Cell Adhesion Molecules in Immune and Cancer Therapy
OCT 18, 2022
Cell Adhesion Molecules in Immune and Cancer Therapy
Introduction The immune system plays a dual role in inflammation and cancer development. Immune system effector cells ra ...
NOV 15, 2022
Genetics & Genomics
Revealing the Mutations that Make Melanoma Immortal
NOV 15, 2022
Revealing the Mutations that Make Melanoma Immortal
Telomeres cap the ends of chromosomes, preventing breakage. Some cancer cells can use those protective caps to their adv ...
NOV 17, 2022
Drug Discovery & Development
Implantable Pump Delivers Chemotherapy Directly to the Brain
NOV 17, 2022
Implantable Pump Delivers Chemotherapy Directly to the Brain
An implantable pump can bypass the blood-brain barrier and deliver chemotherapy to specific brain areas. The correspondi ...
Loading Comments...